UnitedHealth Group Profits Eclipse $6 Billion As Medical Costs Ease
UnitedHealth Group Raises Earnings Outlook for 2026
UnitedHealth Group, the parent company of UnitedHealthcare, has raised its full-year 2026 earnings outlook to “greater than $17.35 per share,” up from the previous forecast of “greater than $17.10 per share.” The company reported first-quarter net income of $6.3 billion, with a decrease in medical costs leading to an improved outlook for the year ahead.
Getty Images
The first quarter of 2026 saw UnitedHealth Group achieve a net income of $6.3 billion, with medical costs experiencing a slight decline. As a result, the company has raised its earnings outlook for the full year to exceed $17.35 per share, compared to the initial projection of exceeding $17.10 per share.
The company attributed the improved outlook to a medical care ratio of 83.9% in the first quarter of 2026, down from 84.8% in the same period last year. This decrease was driven by effective medical cost management and favorable reserve development, although it was partially offset by elevated utilization and unit cost trends.
UnitedHealth reported a net income of $6.28 billion, or $6.90 per share, for the first quarter ended March 31, 2026, compared to $6.29 billion, or $6.85 per share, in the corresponding quarter of the previous year. Total company revenues grew by 2% to $111.7 billion, with certain Optum businesses contributing to this growth, including OptumRx, the company’s pharmacy benefit unit.
Health insurers have been experiencing challenges with rising medical costs, with some seeing medical loss ratios exceed 90%. UnitedHealthcare has been able to improve its medical cost picture by exiting unprofitable markets and discontinuing certain health plans, resulting in a decline in health plan members.
Despite the decrease in members, UnitedHealthcare saw an increase in revenues to $86.3 billion in the first quarter of 2026, compared to $84.6 billion in the same period last year. The company’s earnings from operations also rose to $5.7 billion from $5.2 billion in the first quarter of 2025.
Overall, UnitedHealth Group’s performance in the first quarter of 2026 has been positive, with the company strategically managing its medical costs and making necessary adjustments to improve its financial outlook for the year.
